Letter: From Descriptive Epidemiology to Clinical Imperative—Challenging the Paradigm of Pain and Sedative Use in Inflammatory Bowel Disease

Documenti analoghi

• Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study
  di: Samantha Baillie, et al.
  Pubblicazione: (2025)
• Letter: Are All Extra‐Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story?
  di: Liang Jiao, et al.
  Pubblicazione: (2026)
• The Impact of Antispasmodic Use on Abdominal Pain and Opioid Use in Inflammatory Bowel Disease: A Population‐Based Study
  di: Chachrit Khunsriraksakul, et al.
  Pubblicazione: (2025)
• Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity
  di: Brigida Barberio, et al.
  Pubblicazione: (2026)
• Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease
  di: Cong Dai, et al.
  Pubblicazione: (2024)